fda warning letters compounded semaglutide tirzepatide 2025 🚨 Moves to Permanently Shut Down GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these Out of Shortage, Into Controversy:

Relation of elevated heart rate in patients with heart failure with reduced ejection fraction to one-year outcomes and costs

The current GLP-1 + Frother LP promotional pricing takes a meaningful chunk off the per-jar cost

Glucagon typically raises blood glucose and promotes fat breakdown, but when combined with GLP-1 activation, the net effect appears to amplify energy expenditure without the problematic blood glucose elevation glucagon would cause alone

Peaka GLP-1 ingredients breakdown Understanding what is actually inside Peaka GLP-1 requires separating marketing language from ingredient reality

It has been this really interesting trend, where ROIC for pharma as an industry over the last 50 years has declined, but the variance between companies has increased